Skip to content

Effect of Immunonutrition in perforation peritonitis patients outcome

Effect of early enteral immunonutrition on inflammatory markers and clinical outcome in patients with perforation peritonitis-A Randomised Control Trial

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/02/080028
Enrollment
50
Registered
2025-02-07
Start date
Unknown
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K650- Generalized (acute) peritonitis

Interventions

Intervention1: L-Glutamine(L-Gln): Patients presenting with perforation peritonitis will be planned for operative procedure as in standardised surgical protocol as per diagnosis. The intervention gro

Sponsors

Post Graduate Institute of Medical Education and Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients aged 18 years to 80 years Perforation of stomach, small bowel and large bowel of any cause needing operative intervention Either sex (male or female) No previous history of nutritional formula supplementation Patients providing informed consent

Exclusion criteria

Exclusion criteria: Patients less than 18 years and more than 80 years Patients presenting with more than two organ failures Patients with localised perforation managed conservatively or by any interventional procedure Patients on mechanical ventilation for more than 72 hours Patients with chronic diseases (chronic liver disease, chronic kidney disease, chronic heart failure) Pregnant or lactating women Patients diagnosed with mental illness Patients diagnosed with immunodeficiency diseases or autoimmune diseases Patients with allergy to any nutritional formulas Patients with intolerance to feeding of immuno nutrition (vomiting or diarrhoea or abdominal distension or abdominal pain lasting for 12 to 24 hours even in minimal flow rate) Discontinuation of enteral nutrition for any reason in the first three days of administration Traumatic surgical patients (polytrauma)

Design outcomes

Primary

MeasureTime frame
Inflammatory markers-total leukocyte count, differential leukocyte count, absolute neutrophil count, absolute lymphocyte count, C-reactive protein, procalcitonin, and albuminTimepoint: At Baseline, 24 hrs(Day 1), 72 hrs(Day 3) and 120 hrs(Day 5)

Secondary

MeasureTime frame
Postoperative complications Readmission ratesTimepoint: 30 day morbidity,mortality

Countries

India

Contacts

Public ContactKarthick M C

Post Graduate Institute of Medical Education and Research

drsnsatish06@gmail.com9790674694

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026